Tralokinumab Significantly Reduces Work Productivity Impairment and Daily Activity Impairment in Adults With Atopic Dermatitis and Moderate-to-Severe Hand Involvement. J of Skin 2026, 10 (2), s726. https://doi.org/10.25251/mjfdzc48.